{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T04:19:48Z","timestamp":1789877988694,"version":"4.0.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T00:00:00Z","timestamp":1738454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T00:00:00Z","timestamp":1738454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-88651-8","type":"journal-article","created":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T20:15:26Z","timestamp":1738527326000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Beta-hydroxy-beta-methylbutyrate (HMB) improves daily activity and whole-body protein metabolism in Duchenne muscular dystrophy dogs: a pilot study"],"prefix":"10.1038","volume":"15","author":[{"given":"Peter P.","family":"Nghiem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis M.","family":"Rutledge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"Tehas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corine","family":"Kaderli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith","family":"Poling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidney","family":"Arnim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitaliy","family":"Dernov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celine","family":"van Sas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Macie L.","family":"Mackey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella A. M. ten","family":"Have","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari\u00eblle P. K. J.","family":"Engelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolaas E. P.","family":"Deutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,2]]},"reference":[{"issue":"2","key":"88651_CR1","first-page":"402","volume":"219","author":"EP Hoffman","year":"1987","unstructured":"Hoffman, E. P., Brown, R. H. & Kunkel, L. M. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 219(2), 402\u2013414 (1987).","journal-title":"Cell"},{"issue":"1","key":"88651_CR2","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/ilar\/ilu011","volume":"55","author":"JN Kornegay","year":"2014","unstructured":"Kornegay, J. N. et al. Pharmacologic management of Duchenne muscular dystrophy: target identification and preclinical trials. ILAR J. 55(1), 119\u2013149 (2014).","journal-title":"ILAR J."},{"issue":"6","key":"88651_CR3","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1083\/jcb.151.6.1321","volume":"151","author":"YW Chen","year":"2000","unstructured":"Chen, Y. W., Zhao, P., Borup, R. & Hoffman, E. P. Expression profiling in the muscular dystrophies: identification of novel aspects of molecular pathophysiology. J. Cell. Biol. 151(6), 1321\u20131336 (2000).","journal-title":"J. Cell. Biol."},{"issue":"5","key":"88651_CR4","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1074\/mcp.M112.023127","volume":"12","author":"S Rayavarapu","year":"2013","unstructured":"Rayavarapu, S. et al. Identification of disease specific pathways using in vivo SILAC proteomics in dystrophin deficient mdx mouse. Mol. Cell. Proteomics. 12(5), 1061\u20131073 (2013).","journal-title":"Mol. Cell. Proteomics."},{"issue":"3","key":"88651_CR5","first-page":"351","volume":"90","author":"PP Nghiem","year":"2017","unstructured":"Nghiem, P. P. et al. Changes in Muscle Metabolism are Associated with Phenotypic Variability in Golden Retriever Muscular Dystrophy. Yale J. Biol. Med. 90(3), 351\u2013360 (2017).","journal-title":"Yale J. Biol. Med."},{"issue":"5","key":"88651_CR6","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1007\/s11307-018-1174-2","volume":"20","author":"SM Schneider","year":"2018","unstructured":"Schneider, S. M. et al. Glucose Metabolism as a Pre-clinical Biomarker for the Golden Retriever Model of Duchenne Muscular Dystrophy. Mol. Imaging Biol. 20(5), 780\u2013788 (2018).","journal-title":"Mol. Imaging Biol."},{"issue":"23","key":"88651_CR7","doi-asserted-by":"publisher","first-page":"5215","DOI":"10.1113\/JP282227","volume":"599","author":"WJ Evans","year":"2021","unstructured":"Evans, W. J. et al. Profoundly lower muscle mass and rate of contractile protein synthesis in boys with Duchenne muscular dystrophy. J. Physiol. 599(23), 5215\u20135227 (2021).","journal-title":"J. Physiol."},{"issue":"1","key":"88651_CR8","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1186\/s13023-023-02885-1","volume":"18","author":"H Xu","year":"2023","unstructured":"Xu, H., Cai, X., Xu, K., Wu, Q. & Xu, B. The metabolomic plasma profile of patients with Duchenne muscular dystrophy: providing new evidence for its pathogenesis. Orphanet. J. Rare Dis. 18(1), 273 (2023).","journal-title":"Orphanet. J. Rare Dis."},{"issue":"4","key":"88651_CR9","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1002\/jcsm.12208","volume":"8","author":"M Holecek","year":"2017","unstructured":"Holecek, M. Beta-hydroxy-beta-methylbutyrate supplementation and skeletal muscle in healthy and muscle-wasting conditions. J. Cachexia Sarcopenia Muscle. 8(4), 529\u2013541 (2017).","journal-title":"J. Cachexia Sarcopenia Muscle."},{"key":"88651_CR10","doi-asserted-by":"publisher","first-page":"155400","DOI":"10.1016\/j.metabol.2023.155400","volume":"142","author":"NEP Deutz","year":"2023","unstructured":"Deutz, N. E. P. et al. Females have a different metabolic response to critical illness, measured by comprehensive amino acid flux analysis. Metabolism 142, 155400 (2023).","journal-title":"Metabolism"},{"issue":"5","key":"88651_CR11","doi-asserted-by":"publisher","first-page":"2876","DOI":"10.1016\/j.clnu.2021.03.015","volume":"40","author":"NEP Deutz","year":"2021","unstructured":"Deutz, N. E. P. et al. Comprehensive metabolic amino acid flux analysis in critically ill patients. Clin. Nutr. 40(5), 2876\u20132897 (2021).","journal-title":"Clin. Nutr."},{"issue":"5","key":"88651_CR12","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1016\/j.clnu.2018.09.025","volume":"38","author":"USU Din","year":"2019","unstructured":"Din, U. S. U. et al. A double-blind placebo-controlled trial into the impacts of HMB supplementation and exercise on free-living muscle protein synthesis, muscle mass and function, in older adults. Clin. Nutr. 38(5), 2071\u20132078 (2019).","journal-title":"Clin. Nutr."},{"key":"88651_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2017.09.024","author":"DJ Wilkinson","year":"2018","unstructured":"Wilkinson, D. J. et al. Impact of the calcium form of \u03b2-hydroxy-\u03b2-methylbutyrate upon human skeletal muscle protein metabolism. Clin. Nutr. https:\/\/doi.org\/10.1016\/j.clnu.2017.09.024 (2018).","journal-title":"Clin. Nutr."},{"key":"88651_CR14","doi-asserted-by":"publisher","first-page":"211","DOI":"10.2478\/hukin-2019-0070","volume":"68","author":"P Kaczka","year":"2019","unstructured":"Kaczka, P. et al. Mechanism of Action and the Effect of Beta-Hydroxy-Beta-Methylbutyrate (HMB) Supplementation on Different Types of Physical Performance - A Systematic Review. J. Hum. Kinet. 68, 211\u2013222 (2019).","journal-title":"J. Hum. Kinet."},{"issue":"1","key":"88651_CR15","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/mus.20436","volume":"33","author":"ET Payne","year":"2006","unstructured":"Payne, E. T. et al. Nutritional therapy improves function and complements corticosteroid intervention in mdx mice. Muscle Nerve. 33(1), 66\u201377 (2006).","journal-title":"Muscle Nerve."},{"issue":"7","key":"88651_CR16","doi-asserted-by":"publisher","first-page":"4702","DOI":"10.1016\/j.clnu.2021.06.008","volume":"40","author":"ZE Davidson","year":"2021","unstructured":"Davidson, Z. E. et al. Effect of a multicomponent nutritional supplement on functional outcomes for Duchenne muscular dystrophy: A randomized controlled trial. Clin. Nutr. 40(7), 4702\u20134711 (2021).","journal-title":"Clin. Nutr."},{"issue":"5","key":"88651_CR17","doi-asserted-by":"publisher","first-page":"101611","DOI":"10.1016\/j.rehab.2021.101611","volume":"65","author":"AM Rutledge","year":"2022","unstructured":"Rutledge, A. M. et al. Comprehensive assessment of physical activity correlated with muscle function in canine Duchenne muscular dystrophy. Ann. Phys. Rehabil. Med. 65(5), 101611 (2022).","journal-title":"Ann. Phys. Rehabil. Med."},{"key":"88651_CR18","unstructured":"Pincus M.R., McPherson R.A., Bock J. Chemical Basis for Analyte Assays and Common Interferences. Henry\u2019s Clinical Diagnosis and Management by Laboratory Methods. Elsevier. Ch 28. 453\u2013466.e1."},{"issue":"3","key":"88651_CR19","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/MCO.0000000000000459","volume":"21","author":"MPKJ Engelen","year":"2018","unstructured":"Engelen, M. P. K. J. & Deutz, N. Is \u03b2-hydroxy \u03b2-methylbutyrate an effective anabolic agent to improve outcome in older diseased populations?. Curr. Opin. Clin. Nutr. Metab. Care. 21(3), 207\u2013213 (2018).","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care."},{"issue":"3","key":"88651_CR20","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.clnu.2020.08.031","volume":"40","author":"NE Deutz","year":"2021","unstructured":"Deutz, N. E. et al. Reduced mortality risk in malnourished hospitalized older adult patients with COPD treated with a specialized oral nutritional supplement: Sub-group analysis of the NOURISH study. Clin. Nutr. 40(3), 1388\u20131395 (2021).","journal-title":"Clin. Nutr."},{"key":"88651_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2023.155399","author":"SK Kirschner","year":"2023","unstructured":"Kirschner, S. K. et al. Short-chain fatty acid production in accessible and inaccessible body pools as assessed by novel stable tracer pulse approach is reduced by aging independent of presence of COPD. Metabolism https:\/\/doi.org\/10.1016\/j.metabol.2023.155399 (2023).","journal-title":"Metabolism"},{"key":"88651_CR22","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.metabol.2017.09.015","volume":"78","author":"NEP Deutz","year":"2018","unstructured":"Deutz, N. E. P. et al. Metabolic phenotyping using kinetic measurements in young and older healthy adults. Metabolism 78, 167\u2013178 (2018).","journal-title":"Metabolism"},{"key":"88651_CR23","doi-asserted-by":"crossref","unstructured":"Kang M., et al., Aging induced changes in arginine metabolism is dependent on sex, Clinical Nutrition ESPEN. Volume 58, Pages 487\u2013488, ISSN 2405\u20134577. (2023).","DOI":"10.1016\/j.clnesp.2023.09.185"},{"key":"88651_CR24","doi-asserted-by":"publisher","first-page":"1388969","DOI":"10.3389\/fnut.2024.1388969","volume":"11","author":"NEP Deutz","year":"2024","unstructured":"Deutz, N. E. P. & Engelen, M. P. K. J. Compartmental analysis: a new approach to estimate protein breakdown and meal response in health and critical illness. Front. Nutr. 11, 1388969 (2024).","journal-title":"Front. Nutr."},{"key":"88651_CR25","unstructured":"Wolfe R.R. and Chinkes, D.L. Isotope tracers in metabolic research: principles and practice of kinetic analysis. New York, Wiley: 1\u2013274. (2005)."},{"issue":"2","key":"88651_CR26","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1177\/0023677217718003","volume":"52","author":"GAM Ten Have","year":"2018","unstructured":"Ten Have, G. A. M., Deutz, R. C., Engelen, M. P. K. J., Wolfe, R. R. & Deutz, N. E. P. Characteristics of a Pseudomonas aeruginosa induced porcine sepsis model for multi-organ metabolic flux measurements. Lab Anim. 52(2), 163\u2013175 (2018).","journal-title":"Lab Anim."},{"issue":"12","key":"88651_CR27","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.clnu.2024.10.015","volume":"43","author":"MC Kang","year":"2024","unstructured":"Kang, M. C., Deutz, N. E. P., Kirschner, S. K. & Engelen, M. P. K. J. Metabolic kinetics and muscle and brain health markers in older adults, and the role of age and presence of chronic morbidities: A large cross-sectional cohort study. Clin. Nutr. 43(12), 36\u201347 (2024).","journal-title":"Clin. Nutr."},{"issue":"8","key":"88651_CR28","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.mri.2012.04.003","volume":"30","author":"AB Martins-Bach","year":"2012","unstructured":"Martins-Bach, A. B., Bloise, A., Vainzof, M. & Rahnamaye Rabbani, S. Metabolic profile of dystrophic mdx mouse muscles analyzed with in vitro magnetic resonance spectroscopy (MRS). Magn. Reson. Imaging. 30(8), 1167\u20131176 (2012).","journal-title":"Magn. Reson. Imaging."},{"key":"88651_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s13395-023-00325-z","author":"MDSV Lorena","year":"2023","unstructured":"Lorena, M. D. S. V. et al. Biomarkers for Duchenne muscular dystrophy progression: impact of age in the mdx tongue spared muscle. Skelet. Muscle. https:\/\/doi.org\/10.1186\/s13395-023-00325-z (2023).","journal-title":"Skelet. Muscle."},{"key":"88651_CR30","doi-asserted-by":"publisher","first-page":"102040","DOI":"10.1016\/j.redox.2021.102040","volume":"45","author":"E Panza","year":"2021","unstructured":"Panza, E. et al. Duchenne\u2019s muscular dystrophy involves a defective transsulfuration pathway activity. Redox Biol. 45, 102040 (2021).","journal-title":"Redox Biol."},{"key":"88651_CR31","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.cca.2017.12.036","volume":"478","author":"NK Srivastava","year":"2018","unstructured":"Srivastava, N. K., Yadav, R., Mukherjee, S. & Sinha, N. Perturbation of muscle metabolism in patients with muscular dystrophy in early or acute phase of disease: In vitro, high resolution NMR spectroscopy-based analysis. Clin. Chim. Acta. 478, 171\u2013181 (2018).","journal-title":"Clin. Chim. Acta."},{"issue":"11","key":"88651_CR32","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.1113\/JP271418","volume":"594","author":"JR Terrill","year":"2016","unstructured":"Terrill, J. R., Pinniger, G., Graves, J. A., Grounds, M. D. & Arthur, P. G. Increasing taurine intake and taurine synthesis improves skeletal muscle function in the mdx mouse model for Duchenne muscular dystrophy. J Physiol. 594(11), 3095\u20133110 (2016).","journal-title":"J Physiol."},{"issue":"3","key":"88651_CR33","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/BF00857525","volume":"240","author":"H Kawai","year":"1993","unstructured":"Kawai, H. et al. Decrease in urinary excretion of 3-methylhistidine by patients with Duchenne muscular dystrophy during glucocorticoid treatment. J. Neurol. 240(3), 181\u2013186 (1993).","journal-title":"J. Neurol."},{"issue":"5","key":"88651_CR34","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/j.ymthe.2020.03.003","volume":"28","author":"C Lin","year":"2020","unstructured":"Lin, C. et al. Glycine Enhances Satellite Cell Proliferation, Cell Transplantation, and Oligonucleotide Efficacy in Dystrophic Muscle. Mol. Ther. 28(5), 1339\u20131358 (2020).","journal-title":"Mol. Ther."},{"issue":"6","key":"88651_CR35","doi-asserted-by":"publisher","first-page":"e53955","DOI":"10.15252\/embr.202153955","volume":"23","author":"C Lin","year":"2022","unstructured":"Lin, C. et al. Cardio-respiratory and phenotypic rescue of dystrophin\/utrophin-deficient mice by combination therapy. EMBO Rep. 23(6), e53955 (2022).","journal-title":"EMBO Rep."},{"issue":"1","key":"88651_CR36","doi-asserted-by":"publisher","first-page":"12982","DOI":"10.1038\/s41598-019-49140-x","volume":"9","author":"DJ Ham","year":"2019","unstructured":"Ham, D. J. et al. Glycine administration attenuates progression of dystrophic pathology in prednisolone-treated dystrophin\/utrophin null mice. Sci. Rep. 9(1), 12982 (2019).","journal-title":"Sci. Rep."},{"issue":"10","key":"88651_CR37","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1007\/s00726-018-2614-7","volume":"50","author":"E Hanff","year":"2018","unstructured":"Hanff, E. et al. Effects of single and combined metformin and L-citrulline supplementation on L-arginine-related pathways in Becker muscular dystrophy patients: possible biochemical and clinical implications. Amino Acids 50(10), 1391\u20131406 (2018).","journal-title":"Amino Acids"},{"issue":"6","key":"88651_CR38","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/S0261-5614(99)80017-X","volume":"18","author":"R Hankard","year":"1999","unstructured":"Hankard, R., Mauras, N., Hammond, D., Haymond, M. & Darmaun, D. Is glutamine a \u201cconditionally essential\u201d amino acid in Duchenne muscular dystrophy?. Clin. Nutr. 18(6), 365\u2013369 (1999).","journal-title":"Clin. Nutr."},{"issue":"4","key":"88651_CR39","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1093\/ajcn\/83.4.823","volume":"83","author":"E Mok","year":"2006","unstructured":"Mok, E. et al. Oral glutamine and amino acid supplementation inhibit whole-body protein degradation in children with Duchenne muscular dystrophy. Am. J. Clin. Nutr. 83(4), 823\u2013828 (2006).","journal-title":"Am. J. Clin. Nutr."},{"key":"88651_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0020856","author":"LT Bish","year":"2011","unstructured":"Bish, L. T. et al. Chronic losartan administration reduces mortality and preserves cardiac but not skeletal muscle function in dystrophic mice. PLoS One. https:\/\/doi.org\/10.1371\/journal.pone.0020856 (2011).","journal-title":"PLoS One."},{"issue":"2","key":"88651_CR41","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1002\/mus.20681","volume":"35","author":"LE Gosselin","year":"2007","unstructured":"Gosselin, L. E., Williams, J. E., Personius, K. & Farkas, G. A. A comparison of factors associated with collagen metabolism in different skeletal muscles from dystrophic (mdx) mice: impact of pirfenidone. Muscle Nerve. 35(2), 208\u2013216 (2007).","journal-title":"Muscle Nerve."},{"issue":"1","key":"88651_CR42","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/mus.24998","volume":"54","author":"LR Smith","year":"2016","unstructured":"Smith, L. R. et al. Increased collagen cross-linking is a signature of dystrophin-deficient muscle. Muscle Nerve. 54(1), 71\u201378 (2016).","journal-title":"Muscle Nerve."},{"key":"88651_CR43","doi-asserted-by":"crossref","unstructured":"Abdullah, M. et al. Non-Targeted Metabolomics Analysis of Golden Retriever Muscular Dystrophy-Affected Muscles Reveals Alterations in Arginine and Proline Metabolism, and Elevations in Glutamic and Oleic Acid In Vivo. Metabolites. 7(3). (2017).","DOI":"10.3390\/metabo7030038"},{"issue":"10","key":"88651_CR44","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.nmd.2019.08.009","volume":"29","author":"JF Boehler","year":"2019","unstructured":"Boehler, J. F. et al. Membrane recruitment of nNOS\u00b5 in microdystrophin gene transfer to enhance durability. Neuromuscul. Disord. 29(10), 735\u2013741 (2019).","journal-title":"Neuromuscul. Disord."},{"issue":"5","key":"88651_CR45","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1093\/hmg\/ddz309","volume":"29","author":"R Tsonaka","year":"2020","unstructured":"Tsonaka, R. et al. Longitudinal metabolomic analysis of plasma enables modeling disease progression in Duchenne muscular dystrophy mouse models. Hum. Mol. Genet. 29(5), 745\u2013755 (2020).","journal-title":"Hum. Mol. Genet."},{"issue":"4","key":"88651_CR46","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1111\/jcmm.13543","volume":"22","author":"P Spitali","year":"2018","unstructured":"Spitali, P. et al. Cross-sectional serum metabolomic study of multiple forms of muscular dystrophy. J. Cell Mol. Med. 22(4), 2442\u20132448 (2018).","journal-title":"J. Cell Mol. Med."},{"key":"88651_CR47","doi-asserted-by":"crossref","unstructured":"Doi M., et al. Isoleucine, a blood glucose-lowering amino acid, increases glucose uptake in rat skeletal muscle in the absence of increases in AMP-activated protein kinase activity. J. Nutr. 135(9):2103\u20138. (2005).","DOI":"10.1093\/jn\/135.9.2103"},{"issue":"10","key":"88651_CR48","doi-asserted-by":"publisher","first-page":"e153837","DOI":"10.1172\/JCI153837","volume":"133","author":"AJ Russell","year":"2023","unstructured":"Russell, A. J. et al. Modulating fast skeletal muscle contraction protects skeletal muscle in animal models of Duchenne muscular dystrophy. J. Clin. Invest. 133(10), e153837 (2023).","journal-title":"J. Clin. Invest."},{"key":"88651_CR49","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.nut.2018.09.032","volume":"60","author":"Y Zhong","year":"2019","unstructured":"Zhong, Y. et al. \u03b2-hydroxy-\u03b2-methylbutyrate (HMB) improves mitochondrial function in myocytes through pathways involving PPAR\u03b2\/\u03b4 and CDK4. Nutrition 60, 217\u2013226 (2019).","journal-title":"Nutrition"},{"key":"88651_CR50","doi-asserted-by":"crossref","unstructured":"Sadeghi B., et al. Effects of \u03b2-hydroxy-\u03b2-methylbutyrate (HMB) supplementation on lipid profile in adults: a GRADE-assessed systematic review and meta-analysis of randomized controlled trials. Front. Nutr. (2024).","DOI":"10.3389\/fnut.2024.1451282"},{"key":"88651_CR51","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abo1815","author":"SM Birch","year":"2023","unstructured":"Birch, S. M. et al. Assessment of systemic AAV-microdystrophin gene therapy in the GRMD model of Duchenne muscular dystrophy. Sci. Transl. Med. https:\/\/doi.org\/10.1126\/scitranslmed.abo1815 (2023).","journal-title":"Sci. Transl. Med."},{"issue":"4","key":"88651_CR52","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3233\/JND-210776","volume":"9","author":"WD Biggar","year":"2022","unstructured":"Biggar, W. D., Skalsky, A. & McDonald, C. M. Comparing Deflazacort and Prednisone in Duchenne Muscular Dystrophy. J. Neuromuscul. Dis. 9(4), 463\u2013476 (2022).","journal-title":"J. Neuromuscul. Dis."},{"issue":"10","key":"88651_CR53","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1001\/jamaneurol.2022.2480","volume":"79","author":"M Guglieri","year":"2022","unstructured":"Guglieri, M. et al. Efficacy and Safety of Vamorolone vs Placebo and Prednisone Among Boys With Duchenne Muscular Dystrophy: A Randomized Clinical Trial. JAMA Neurol. 79(10), 1005\u20131014 (2022).","journal-title":"JAMA Neurol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88651-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88651-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88651-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T20:15:30Z","timestamp":1738527330000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88651-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,2]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["88651"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-88651-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,2]]},"assertion":[{"value":"22 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"PPN is a paid consultant of Agada Biosciences, a scientific advisory board member of Bioramics, LLC, and has an equity stake in SCRM-Bio. The other authors do not report any competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4026"}}